3738985

Synthesis of mannose-6-phosphonate conjugate for targeted protein degradation through the lysosome | Poster Board #2407

Date
August 21, 2022

The binding and tagging of specific protein targets for degradation is a key area of medicinal chemistry and drug development that has become increasingly important as our knowledge of protein/ligand interactions improves. There are several different currently developed routes to targeted protein degradation, mainly through molecular glues, hydrophobic tagging of the target, and heterobifunctional proteolysis targeting chimeras. However, these strategies can only target intracellular proteins. About 40% of proteins in the proteome are outside the cells and many of them are associated with various diseases such as cancer. Lysosome targeting degraders are heterobifunctional molecules that contain a ligand for the protein target to be degraded and a ligand for cell internalization to a lysosomal compartment, which can complement existing strategies for intracellular proteins. One such target for cell internalization is the Mannose-6-Phosphate Receptor (M6PR). Current synthesis of the ligands for M6PR depend on large multivalences in Mannose-6-phosphate (M6P) that require long synthetic paths and are not optimized in their cell internalization. Our goal was to improve upon the synthesis of these lysosome targeting chimeras, and to probe the more exact binding requirements between M6P and its receptor. Our synthetic route for LYTACs streamlines those previously explored for M6P based lysosome targeting degraders and protein degradation studies have shown effective degradation of target proteins at sub micromolar concentrations of the chimera, which validates the refined models.

Related Products

Thumbnail for Asialoglycoprotein receptor (ASGPR) ligand development for Lysosome targeting chimeras (LYTACs) | Poster Board #586
Asialoglycoprotein receptor (ASGPR) ligand development for Lysosome targeting chimeras (LYTACs) | Poster Board #586
Targeted protein degradation has a great potential for the development of novel classes of therapeutics…
Thumbnail for Suzuki cross-coupling platform for phenyl linker attachment in the development of a cereblon E3 ligase-based partial PROTAC library
Suzuki cross-coupling platform for phenyl linker attachment in the development of a cereblon E3 ligase-based partial PROTAC library
Proteolysis Targeting Chimeras (PROTACs) present a promising therapeutic approach for selectively degrading targeted proteins via the ubiquitin-proteasome system…
Thumbnail for Synthetic receptors for precise manipulation of defined synaptic connections
Synthetic receptors for precise manipulation of defined synaptic connections
Tools for manipulating the activity of specific cell populations in the brain have been transformative for neuroscience, allowing scientists to establish ‘causal’ relationships between cell populations and behavior…